hotspot -WSS

hotspot

author：explore 2025-09-06 02:11:09 - browse：512

Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month. The surprise announcement comes just days after Eisai won final approval in the U.S. for its Alzheimer’s drug Leqembi.

Cheung will be replaced in his capacity as head of the Alzheimer’s unit by his brother-in-law Keisuke Naito, 34, who is currently chief ecosystem officer and chief strategy officer. He is also the son of Eisai CEO Haruo Naito.

Tatsuyuki Yasuno, current chief financial officer, will replace Cheung as head of Eisai’s U.S. unit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Doctors find melanoma drugs effective against rare brain cancer

leisure time

WSS

Extensive review finds private equity owners jack up cost of care

Key House panel plots a new health care package

Key House panel plots a new health care package

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare to cover more brain scans for Alzheimer’s patients

Cosmetics set for new safety regulation. Why the industry is on board

entertainment

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Sanofi seeks simpler, safer CRISPR sickle cell cure

Apple is now the first public company to be valued at $3 trillion

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

As demand for Covid shots wanes, Moderna seeks its next success

Scientists grapple with ethics of stem cell research

At least 13 dead in Texas as scorching temps continue

FDA approves RSV monoclonal antibody for infants, toddlers

The cancer drug shortage isn’t new — and neither are the solutions

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

hotspot

Sanders adds drug shortage policies to pandemic preparedness bill

A new ‘biological computer' targets cancer while sparing healthy cells

Startup Neumora takes a novel depression drug to Phase 3

Google and Epic fight stronger regulation of AI in health care

Mystery swirls around US soldier who entered North Korea days ago, officials say

Why hospitals are withdrawing from US News rankings

leisure time

hotspot

knowledge

hotspot